AbbVie traded at $164.76 this Wednesday December 7th, increasing $1.04 or 0.64 percent since the previous trading session. Looking back, over the last four weeks, AbbVie gained 10.93 percent. Over the last 12 months, its price rose by 35.19 percent. Looking ahead, we forecast AbbVie to be priced at 158.36 by the end of this quarter and at 143.46 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
164.76
Daily Change
0.64%
Yearly
35.19%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Eisai 9,741.00 18.00 0.19% 40.64%
AbbVie 164.76 1.04 0.64% 35.19%
Abbott 104.77 0.91 0.88% -20.85%
ALKERMES 25.21 0.21 0.84% 9.75%
Amgen 285.52 2.23 0.79% 33.71%
AstraZeneca 11,258.00 108.00 0.97% 35.90%
AstraZeneca 68.69 0.13 0.18% 24.59%
Biogen 292.09 0.62 0.21% 24.44%
BioMarin Pharmaceutical 103.76 1.54 1.51% 17.40%
Bristol-Myers Squibb 79.90 -0.02 -0.03% 38.72%
Coherus Biosciences 6.67 -0.14 -1.99% -63.26%
Endo International 0.09 -0.002 -1.63% -98.28%
Gilead Sciences 87.91 -0.05 -0.06% 26.11%
GlaxoSmithKline 1,492.40 104.60 7.54% -6.24%
Horizon Pharma 96.64 -0.21 -0.22% -7.12%
Intercept Pharmaceuticals 14.40 0.41 2.93% -15.84%
Infinity Pharmaceuticals 0.49 -0.003 -0.69% -79.43%
Jazz Pharmaceuticals 150.84 0.91 0.61% 19.61%
J&J 177.19 1.09 0.62% 7.82%
Eli Lilly 371.24 2.70 0.73% 51.95%
Medtronic 76.78 -0.30 -0.39% -31.70%
Merck & Co 110.06 1.13 1.04% 50.33%
Neurocrine Biosciences 121.26 1.05 0.87% 43.91%
Novartis 85.78 0.50 0.59% 14.65%
Pacira 46.30 -0.67 -1.43% -21.02%
Pfizer 50.28 0.57 1.15% -2.18%
Perrigo 31.62 -0.12 -0.36% -15.74%
Ultragenyx Pharmaceutical 39.50 0.28 0.71% -51.24%
Regeneron Pharmaceuticals 764.82 17.35 2.32% 16.94%
Roche Holding 301.20 -4.00 -1.31% -19.23%
Revance Therapeutics 21.35 -0.38 -1.75% 28.31%
Sanofi 90.60 5.21 6.10% 7.09%
Teva Pharmaceutical Industries 8.47 -0.08 -0.94% 0.12%
UCB 72.76 1.62 2.28% -26.52%
United Therapeutics 275.01 -1.59 -0.57% 41.80%
Vertex Pharmaceuticals 316.29 4.48 1.44% 53.09%
Zoetis 149.85 -3.20 -2.09% -34.74%

Indexes Price Day Year
US500 3930 -11.29 -0.29% -16.41%

AbbVie
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.